Perceptive Advisors LLC lessened its stake in Omada Health, Inc. (NASDAQ:OMDA – Free Report) by 67.2% in the 1st quarter, according to its most recent filing with the SEC. The fund owned 786,330 shares of the company’s stock after selling 1,610,000 shares during the period. Perceptive Advisors LLC owned about 1.32% of Omada Health worth $9,884,000 at the end of the most recent quarter.
A number of other large investors also recently added to or reduced their stakes in OMDA. Raymond James Financial Inc. acquired a new stake in shares of Omada Health in the second quarter valued at $32,000. Quarry LP acquired a new position in Omada Health during the 4th quarter worth about $29,000. TD Waterhouse Canada Inc. purchased a new position in Omada Health during the 4th quarter valued at about $32,000. Inlight Wealth Management LLC purchased a new position in Omada Health during the 4th quarter valued at about $45,000. Finally, JPMorgan Chase & Co. acquired a new position in Omada Health in the 3rd quarter valued at about $82,000.
Omada Health Stock Performance
OMDA stock opened at $19.84 on Friday. The company’s 50 day moving average price is $19.99 and its 200 day moving average price is $16.03. Omada Health, Inc. has a fifty-two week low of $10.28 and a fifty-two week high of $26.92. The firm has a market capitalization of $1.18 billion and a price-to-earnings ratio of -73.48.
Analysts Set New Price Targets
Several analysts have recently issued reports on OMDA shares. The Goldman Sachs Group reissued a “buy” rating on shares of Omada Health in a research report on Friday, May 8th. Needham & Company LLC reaffirmed a “buy” rating and set a $28.00 target price on shares of Omada Health in a research note on Friday, May 8th. Canaccord Genuity Group increased their target price on shares of Omada Health from $24.00 to $28.00 and gave the stock a “buy” rating in a report on Tuesday, July 21st. Wells Fargo & Company boosted their price target on shares of Omada Health from $17.00 to $18.00 and gave the stock an “equal weight” rating in a research note on Friday, May 8th. Finally, Evercore reaffirmed an “outperform” rating and set a $20.00 price objective on shares of Omada Health in a research report on Friday, May 8th. Eleven investment analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $24.33.
Read Our Latest Analysis on OMDA
Insider Buying and Selling
In other Omada Health news, CAO Craig Gracey sold 6,894 shares of Omada Health stock in a transaction dated Friday, June 12th. The stock was sold at an average price of $17.42, for a total transaction of $120,093.48. Following the completion of the sale, the chief accounting officer directly owned 9,191 shares of the company’s stock, valued at $160,107.22. The trade was a 42.86% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, CEO Sean P. Duffy sold 25,886 shares of the company’s stock in a transaction dated Wednesday, July 1st. The stock was sold at an average price of $22.68, for a total value of $587,094.48. Following the transaction, the chief executive officer directly owned 411,861 shares of the company’s stock, valued at approximately $9,341,007.48. This represents a 5.91% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Over the last quarter, insiders sold 193,462 shares of company stock worth $3,927,425. Corporate insiders own 6.38% of the company’s stock.
Omada Health Company Profile
Omada Health is a digital health company that specializes in the prevention and management of chronic conditions through personalized, technology-driven programs. The company’s platform combines data analytics, behavioral science and human coaching to support individuals at risk for or living with conditions such as prediabetes, type 2 diabetes, hypertension and musculoskeletal disorders. Participants access the program via a mobile app or web portal, where they receive tailored curriculum, feedback on health metrics and ongoing virtual coaching.
In addition to its core disease-management offerings, Omada Health has expanded its services to include mental health support and digital therapeutics for weight management.
Featured Articles
- Five stocks we like better than Omada Health
- Popular’s Earnings Beat Shows Why This Bank Stock Keeps Climbing
- ABB’s Rotork Deal Could Put These Flow Control Stocks Back in Focus
- GE HealthCare Stock Climbs on Vital Diagnostics Demand
- Lost in Space: Why Aerospace Valuations Are Plummeting Right Now
Receive News & Ratings for Omada Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omada Health and related companies with MarketBeat.com's FREE daily email newsletter.
